0001209191-21-026217.txt : 20210409
0001209191-21-026217.hdr.sgml : 20210409
20210409161409
ACCESSION NUMBER: 0001209191-21-026217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210407
FILED AS OF DATE: 20210409
DATE AS OF CHANGE: 20210409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Renaud Ronald C JR
CENTRAL INDEX KEY: 0001354434
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38550
FILM NUMBER: 21817991
MAIL ADDRESS:
STREET 1: C/O IDENIX PHARMACEUTICALS, INC.
STREET 2: 60 HAMPSHIRE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Translate Bio, Inc.
CENTRAL INDEX KEY: 0001693415
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 611807780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-945-7361
MAIL ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: RaNA Therapeutics, Inc.
DATE OF NAME CHANGE: 20161228
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-07
0
0001693415
Translate Bio, Inc.
TBIO
0001354434
Renaud Ronald C JR
C/O TRANSLATE BIO, INC.
29 HARTWELL AVE
LEXINGTON
MA
02421
1
1
0
0
Chief Executive Officer
Common Stock
2021-04-07
4
M
0
9026
7.39
A
503321
D
Common Stock
409913
I
By Ronald Renuad 2014 Irrevocable Family Trust
Common Stock
40909
I
By Ronald C. Renaud, Jr. Trust - 2007
Stock Option (right to buy)
7.39
2021-04-07
4
M
0
9026
0.00
D
2027-12-21
Common Stock
9026
1071009
D
This option was granted on December 22, 2017. The shares underlying the option vested over four years in equal monthly installments through March 9, 2021.
/s/ Paul Burgess, as attorney-in-fact for Ronald C. Renaud, Jr.
2021-04-08